Boots sweetens £9bn pill with margin flex, backstop trading bid

© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Boots sweetens £9bn pill with margin flex, backstop trading bid

The banks leading the £9.02bn leveraged loan for the buy-out of Alliance Boots look set to sweeten the deal’s pricing and offer secondary market support, as bankers away from the leads said it was struggling to attract commitments.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request demo or Login
  • 4,000 annual insights
  • 700+ notes and long-form analyses
  • European securitization issuance database
  • Daily newsletters across markets and asset classes
  • 1 weekly securitization podcast

Related articles

Gift this article